Niki BioSolutions, Inc. (NIKI)

Niki BioSolutions, Inc. (NIKI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.7M; returns 1 day -1.6%, 1 week -9.9%.

Niki BioSolutions, Inc. (formerly Aptorum Group Limited) is a specialized biopharmaceutical and diagnostics company that emerged in July 2026 following a strategic merger with DiamiR Biosciences and a subsequent corporate redomiciliation to Delaware.

Groups NIKI belongs to

• Recent Reverse Splits
• Recent IPOs
• Biotechnology
• Health Diagnostics and Imaging
• Healthcare Innovation
• Precision Medicine
• Neuroscience
• Alzheimer's Disease
• Neurological Disorders
• Biopharmaceutical
• Life Sciences

NIKI financial model: income statement, cash flow and balance sheet